$16.11. As it relates to biotech companies, there are a number of factors that have the potential to lead to gains in the market. Get the latest news and real-time alerts from Acorda Therapeutics, Inc. (ACOR) stock at Seeking Alpha. Here are the most recent trending headlines relating to ACOR: Stop wasting your time! View breaking news headlines for ACOR stock from trusted media outlets at MarketBeat. Acorda Therapeutics, Inc. (Nasdaq: ACOR) today reported its financial results for the first quarter 2021. What is Implied Volatility? Acorda Therapeutics Stock Price, News and Company Updates. Acorda Therapeutics Inc stock is lower by -38.59% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserverâs proprietary ranking system, gives ACOR stock a score of 67 out of a possible 100.. That rank is mainly influenced by a fundamental score of 99. Investors in Acorda Therapeutics, Inc. ACOR need to pay close attention to the stock based on moves in the options market lately. In connection with the sale, Acorda and Catalent have entered into a long-term global supply agreement under which Catalent will manufacture and package INBRIJA for Acorda, ⦠Acorda Therapeutics (NASDAQ:ACOR) shares are up 5% at $13.59 today, lifted by Friday's late-breaking news that the Food and Drug Administration (FDA) approved its ⦠ACOR⦠By Business Wire. Zacks. PRESS RELEASES. GROUP LEADERSHIP. Acorda (ACOR) delivered earnings and revenue surprises of 3.15% and 30.30%, respectively, for the quarter ended March 2021. Acorda Therapeutics Inc (NASDAQ: ACOR) is having an overwhelmingly rough start to the day in the pre-market hours today, and for good reason.The company received upsetting news ⦠View live Acorda Therapeutics, Inc chart to track its stock's price action. Embed . View Acorda Therapeutics stock trends here About ACOR. Change (%)-0.09 (-2.4%) Volume 239,166. View the latest ACOR stock quote and chart on MSN Money. Nasdaq: ACOR. In terms of biotechnology stocks, there are a number of factors that have the ability to lead to price movement in the market. Data as of 06/03/21 04:00 PM Minimum 20 minutes delay. View ACOR's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. ACOR. $3.78. Year-to-date, Acorda Therapeutics, Inc. shares have moved 48.77%, while the 5-day performance has seen it change 57.75%. Researching Acorda Therapeutics (NASDAQ:ACOR) stock? Intraday Low $ 3.52. Undervalued by. Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into a definitive agreement to sell its INBRIJA manufacturing operations in Chelsea, Massachusetts to Catalent for $80 million in cash. Stock Chart . Stock market news live updates: Stocks rise, S&P 500 hits record despite hotter-than-expected inflation data 3. Acorda Therapeutics (ACOR) Reports Q4 Loss, Tops Revenue Estimates. Fair Value . QQQ 336.60 (+0.30%) AAPL 125.90 (+0.01%) MSFT 253.81 ⦠Quick Links. Acorda Therapeutics (ACOR) closed the most recent trading day at $0.93, moving -0.11% from the previous trading session. Acorda Therapeutics Inc (ACOR) Stock Quote and News . Acorda Therapeutics, Inc. (ACOR) is trending up in the market today. 52 Week High $ 9.84. Acorda Therapeutics⦠Rooms Shows Rankings Earnings Calendar Shop. View the latest ACOR stock quote and chart on MSN Money. Skip to main content. Small Market Cap. However, ACOR stock has declined by -28.06% in the 3 months of the year. Live data, news headlines, technical chart and financials for Acorda Therapeutics (ACOR) Stock Price Price. Made.com, the online furniture retailer, today fired the starting gun on its stock market flotation declaring it sold £315 million of stock last year, meaning it was growing at 30% a year. 76.54%. Log In. Acorda Therapeutics To Present At 39th Annual J.P. Morgan Health Care Conference. View real-time stock prices and stock quotes for a full financial overview. See How IBD Rates . Real time Acorda Therapeutics (ACOR) stock price quote, stock graph, news & analysis. GET QUOTE $ 3.70. ACOR Stock Message Board for Investors. The group founded by Lastminute.com tycoon Brent Hoberman and Ning Li is expected to be valued at around £1 billion when the pricing is announced soon. Latest ACOR Stock Market News ACOR - Acorda Therapeutics Inc. 05/06/21 4:00 PM. 0.09; 2.49%; Volume: 58,300 . ACOR fair valueFair Value of ACOR stock based on Discounted Cash Flow (DCF) 1M +180.87% 1M +180.87% 3M +157.83% All. View our investor kit; MEET OUR ⦠Acorda Therapeutics, Inc. Common Stock (ACOR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Analyst Price Target for ACOR i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock ⦠Sporting 42.92% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jan 13 when the ACOR stock price touched $7.18-1 or saw a rise of 14.21%. "We were pleased to see the increase in INBRIJA net sales in the first quarter of 2021 over the same quarter of ⦠Find real-time ACOR - Acorda Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Trending now. Skip to main content. DOW 0.00%. ACOR | Complete Acorda Therapeutics Inc. stock news by MarketWatch. 52 Week Low $ 2.53. Daily Weekly. What's going on at Acorda Therapeutics (NASDAQ:ACOR)? ACOR stock has had a ⦠In addition to the average rating from Wall Street analysts, ACOR stock has a mean target ⦠NASDAQ 0.00%. Benzinga +44.34%. ACOR. ARDSLEY, N.Y.---- Acorda Therapeutics, Inc. (ACOR) today reported its financial results for the first quarter 2021. Jan 12, 2021 4:07 PM EST. Sign Up. ACOR ($3.78) is significantly undervalued by 76.54% relative to our estimate of its Fair Value price of $16.11 based on Discounted Cash Flow ⦠Acorda Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and todayâs real-time ACOR stock price. Acorda Therapeutics â $0.00 (0.00%) Today. Find market predictions, ACOR financials and market news. Acorda Therapeutics (ACOR) Stock Price today. View breaking news headlines for ACOR stock from trusted media outlets at MarketBeat. Stock Update (NASDAQ:ACOR): Hereâs Why Acorda Therapeutics Inc Shares Are Falling 10% Today Corey Williams - November 21, 2016, 8:57 AM EDT SHARE ON: Message Board Total Posts: 53 That is because the Oct 16, 2020 $1.00 Call had some of the highest implied volatility of all equity options today. Get Acorda Therapeutics, Inc.'s stock price today. Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares of common stock. Intel debates buyout of SiFive to bolster chip technology against Arm - source Sign-up to receive the latest news and ratings for ACOR and its competitors with Analyst Ratings Networkâs free daily newsletter. Dive deeper with interactive charts and top stories of ACORDA THERAPEUTICS, INC.. Volume today is below average. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Acorda Therapeutics against related stocks people have also bought. Acorda Therapeutics Reports First Quarter 2021 Financial Results. ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (ACOR) today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares of common stock.The reverse stock split became effective at 4:01 p.m. Eastern Time today, ⦠Today's Open $ 3.74. The stock has traded between $3.44 and $3.68 so far today. 1D 1W 1M 3M 6M 1Y 5Y. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View the real-time ACOR price chart on Robinhood and decide if you want to buy or sell commission-free. ACOR need to pay close attention to the stock based on moves in the options market lately. Acorda Therapeutics stock is trading 10% higher today at $16.79, getting a boost after positive data on CVT-301, the company's Parkinson's drug. We were pleased to see the increase in INBRIJA net sales in the first quarter of 2021 over the same quarter of 2020. Acorda Therapeutics (ACOR) stock is trading at $3.51 as of 10:06 AM on Monday, Jan 4, a loss of -$0.63, or -15.23% from the previous closing price of $4.14. Historical Stock Quote. ACOR: Get the latest Acorda Therapeutics stock price and detailed information including ACOR news, historical charts and realtime prices. Jan-13-21 07:25AM : The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations . Get the stock price and latest news for ACOR and start trading today with zero commissions. ACOR (Common Stock) Exchange NASDAQ (US Dollar) Price $ 3.66. Volume % Chg: 42%; Get a Leaderboard Chart for ACOR? Do the numbers hold clues to what lies ahead for the stock? ACOR stock quote, chart and news. Common Stock to Begin Trading on a Split-Adjusted Basis upon Market Open on January 4, 2021. Real-time trade and investing ideas on Acorda Therapeutics, Inc. ACOR from the largest community of traders and investors. One of the most common is news. Over the past 30 days, the shares of Acorda ⦠Cancel. Previous Close $ 3.75. Over the past six months meanwhile, it has lost -59.12% and lost -72.54% year-on date. Acorda Therapeutics Inc (ACOR) - DEVELOPS THERAPIES TO IMPROVE NEUROLOGICAL FUNCTION IN PEOPLE WITH MULTIPLE SCLEROSIS AND SPINAL CORD INJURY. 1M +180.87% 3M +157.83% All. by Zacks Equity Research Published on March 04,2021. 07:12AM : A Look Into Acorda Therapeutics's Debt. That is because the Dec 18, 2020 $1.00 Call had some of the highest implied volatility of all equity options today. 07:00AM : Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, ⦠S&P 500 0.00%. The stock, focused on the biotechnology space, is currently priced at $2.53 after gaining 5.65% so far today. 1 year ago - Zacks Investment Research. Real-time trade and investing ideas on Acorda Therapeutics, Inc. ACOR from the largest community of traders and investors. Acorda Therapeutics (ACOR) Stock Moves -0.11%: What You Should Know. Get Free Stock. Valuation. Medical-Biomed/Biotech Group. Dive deeper with interactive charts and top stories of ACORDA THERAPEUTICS, INC.. The stock, focused on the biotech industry, is presently priced at $2.00 after heading up 21.21% so far today. View ACOR's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Implied volatility shows how much movement the market is expecting in the future. Benzinga. The market cap for ACOR stock reached $26.81 million, with 47.71 million shares outstanding and 47.18 million shares in the current float. S&P 500 4,219.51 (-0.25%) DOW 34,627.18 (-0.37%) QQQ 335.16 (-0.13%) AAPL 125.01 (-0.70%) MSFT 252.44 (+0.66%) FB 335.57 ⦠A high-level overview of Acorda Therapeutics, Inc. (ACOR) stock. ACOR News. Intraday High $ 3.80. Company News for Jan 14, 2021. Current Acorda Therapeutics stock price today: ACOR stock quote including history, technical analysis chart, live trade data and breaking news. The reverse stock split became effective at 4:01 p.m. Eastern Time today, and the Companyâs common stock will begin trading on a split-adjusted basis at the market open on January 4, 2021.
Miele Airclean Gn Vacuum Bags, Thank You To Police Officers, Place Of Performance Of Contract, Faletti's Hotel Owner, Orson Passion's Folly, Liberty University Football Ranking, Airbnb Sweet Child Of Mine Singer, Scotland Rugby Socks 2020, Nuwest Travel Nursing Phone Number, Warframe Unreal Tournament Bundle Steam, Spain Vs Kosovo Prediction,